0001209191-14-053601.txt : 20140820
0001209191-14-053601.hdr.sgml : 20140820
20140820093655
ACCESSION NUMBER: 0001209191-14-053601
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140819
FILED AS OF DATE: 20140820
DATE AS OF CHANGE: 20140820
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Aegerion Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001338042
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 202960116
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1850
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: (617) 500-7867
MAIL ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1850
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
FORMER COMPANY:
FORMER CONFORMED NAME: Aegerion Pharmaceuticals Inc
DATE OF NAME CHANGE: 20050906
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Fitzpatrick Mark J.
CENTRAL INDEX KEY: 0001520265
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34921
FILM NUMBER: 141053917
MAIL ADDRESS:
STREET 1: 101 MAIN STREET
STREET 2: SUITE 1850
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2014-08-19
0
0001338042
Aegerion Pharmaceuticals, Inc.
AEGR
0001520265
Fitzpatrick Mark J.
C/O AEGERION PHARMACEUTICALS, INC.
101 MAIN STREET, SUITE 1850
CAMBRIDGE
MA
02142
0
1
0
0
Chief Financial Officer
Common Stock
2014-08-19
4
P
0
1150
30.64
A
9500
D
The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $30.57 to $30.68, inclusive. The Reporting Person undertakes to provide to the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range.
/s/ Anne Marie Cook, attorney-in-fact
2014-08-20